CellWell record HH-139951
The effect of CoQ10 supplementation on cardiovascular risk factors in patients with prediabetes and type 2 diabetes mellitus: a grade-assessed systematic review and dose-response meta-analysis
Farzaneh Rezagholizadeh; Soroosh Rezvani; Fatemeh Hosseini Oskouie; Nazgol Bahreini; Seyyed Mostafa Arabi; Reyhaneh Sadeghian; Hadi Fakhari; Reza Bagheri; Damoon Ashtary-Larky; Elham Rastgoo; Matin Ghanavati; Omid Asbaghi
2026
In plain language
A dose-response meta-analysis of 20 RCTs found CoQ10 supplementation significantly reduced triglycerides, fasting blood sugar, HbA1c, HOMA-IR, and CRP while increasing HDL in patients with prediabetes and type 2 diabetes.
- Evidence
- Established
- Design
- Meta-analysis
Cite this record: https://thecellwell.org/studies/HH-139951
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.